Guadecitabine for untreated acute myeloid leukaemia [ID1411]
Discontinued
Reference number: GID-TA10325
Following on from information provided to NICE by the company in August 2018, the appraisal of Guadecitabine for untreated acute myeloid leukaemia [ID1411] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.